Dr Richard Redvers is the Laboratory Manager and Research Assistant in the Blood Cancer Drivers and Therapeutics Laboratory at the Olivia Newton-John Cancer Research Institute, led by Dr Andrew Guirguis. With over 20 years of experience in cancer research, Richard provides strategic and technical leadership in lab operations, experimental design, and preclinical modelling of blood cancers.

Attaining a PhD in Biochemistry and Molecular Biology from the University of Melbourne, Richard has held senior research roles at Peter MacCallum Cancer Centre, Hudson Institute, and ONJCRI. His expertise includes CRISPR-based gene editing, flow cytometry, animal models, RNA sequencing, and molecular cloning.

Richard supports the lab’s mission to uncover the molecular and immunological drivers of Chronic Myelomonocytic Leukaemia (CMML) and develop targeted therapies using advanced genomics and translational models. He oversees lab compliance, supervises junior researchers, and contributes to scientific publications and presentations.

A committed mentor and collaborator, Richard has guided multiple postgraduate students and postdocs, fostering scientific growth and team success. His work underpins the lab’s efforts to translate fundamental discoveries into clinical benefits for patients with blood cancer.